NSC144139
dc.creator | US National Cancer Institute | en_GB |
dc.date.accessioned | 2006-01-13T11:02:58Z | |
dc.date.available | 2006-01-13T11:02:58Z | |
dc.date.created | 2003-02-01 | en_GB |
dc.date.issued | 2006-01-13T11:02:58Z | |
dc.identifier | NSC144139 | en_GB |
dc.identifier.uri | http://www.dspace.cam.ac.uk/handle/1810/112621 | |
dc.format.extent | 19862 bytes | |
dc.format.mimetype | chemical/x-cml | |
dc.language.iso | en_GB | |
dc.publisher | Unilever Center for Molecular Informatics, Cambridge University | en_GB |
dc.title | NSC144139 | en_GB |
dc.title.alternative | Acetic acid, [[1,2-dihydro-5,6,17,19,21-pentahydroxy-23-methoxy-2, 4,12,16,18,20,22-heptamethyl-1,11-dioxo-2,7-(epoxypentadeca[1,11, 13]trienimino)naphtho[2,1-b]furan-9-yl]oxy]-, 21-acetate, 1,2, 2-tripropylhydrazide | en_GB |
dc.title.alternative | Rifamycin B tripropylhydrazide | en_GB |
dc.title.alternative | Rifamycin, 4-O-[2-oxo-2-(tripropylhydrazino)ethyl]- (9CI) | en_GB |
dc.type | Chemical Structures | en_GB |
dc.identifier.inchikey | PPGOZIJHGOGHLF-SCPQPTBISA-N | |
dc.identifier.inchi | InChI=1S/C48H69N3O13/c1-13-20-50(21-14-2)51(22-15-3)36(53)25-61-35-24-33-43(57)38-37(35)39-45(31(9)42(38)56)64-48(11,46(39)58)62-23-19-34(60-12)28(6)44(63-32(10)52)30(8)41(55)29(7)40(54)26(4)17-16-18-27(5)47(59)49-33/h16-19,23-24,26,28-30,34,40-41,44,54-57H,13-15,20-22,25H2,1-12H3,(H,49,59)/b17-16+,23-19+,27-18+/t26-,28+,29-,30-,34+,40-,41-,44+,48-/m1/s1 | |
dc.identifier.ichi | C48H69N3O13,1H3-19H2-22H2-50(23H2-20H2-2H3)51(24H2-21H2-3H3)31(53)25H2-62-30-18H-29-36(57H)33-32(30)34-37(27(5H3)35(33)56H)64-48(11H3,38(34)54)61-17H-16H-44H(60-12H3)41H(8H3)47H(63-28(6H3)52)43H(10H3)46H(59H)42H(9H3)45H(58H)40H(7H3)15H-13H-14H-26(4H3)39(55)49H-29 | en_GB |
Files in this item
This item appears in the following Collection(s)
-
WWMM
The WorldWideMolecularMatrix, an Open collection of information on small molecules